GlaxoSmithKline Invests $360 Mln in U.K. Despite Brexit Vote

JFIF;CREATOR: gd-jpeg v1.0 (using IJG JPEG v62), quality = 80 C   %# , #&')*)-0-(0%()(C   ((((((((((((((((((((((((((((((((((((((((((((((((((( " }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?M}Dz\GNP1UiHN&K\PvSm!+7IWF#Z`RCe{{O><JUa*mB-( :q¿kLS_EeY02F}G&4lR xnan!;\L#ک^\^ZMF>n?>)7iv4}zħ Kl+>2+W@'#uu6#;FZ߈=oǷT|t+3/^v`I'9=gұ$5`>@[VIݞVV:/ kK#+5P,u/9p { Ww4={/ :hT~ߕ9N\ӊ))< ZzjԈ*XǁO E*ͲXU"OflȜR FTKF:wӺ1N5,4K[+˫9v$(Fцpw.=wZ.gs^Lϯ8D̎!l[isG݂n0=:m JZHvV׿KTt$^[I Deͼy;_<.޵f-$l~_Bpq_ Fm;UT<2 :uOcvRY`eVg1>x?NÚR7#͔NL~h d'quvv|WǩIBPX9(O*{^5[{$zRb;\tO_4K; b@z۞jexIjQm-7L;׺$Q#!WqX_SI#ƆerN<4Q<$r+|7Z֘9 d *fE|d{abE۞HF,msE&bYr7!qٓǷ_W?5aV& +#;׎Xiο|us&< /^=>CtZS˧,ҷF>r6np=x}O?u/͍l֛Ғbqn~"3|WmO%Ҍm!çqR:EdZÌn]?ڍ3{7u<3wy"+g,1)Tm)l1US?/$?ŬJj1>=@dDW# SGQqvc ( ( (%PRbI@ Z1KE;RS1NbZJNRLKE6Z)Jq4SCN4LLS(RPRu%0HE: IKIL4 "6%8JJZJ@4Ju%0?|? 3E/iZT#7p@F?B0k5&{RZ_QY'5۳!$#j=τudr7%O`}Jv9QWRtvrZ̀T8 g=:W4Th*ea#V9E<-*@+6JV6hLMkt[B(G@}G;6 i,WV0D sʘSU9,ܛ[s{d&z⍻95uFaX߱VGss[HeBу8_UnD'>". ;gGpb[d!(zrqNҵy]/_T33Q$ Pwg*~eDsG(U01$|ddǐ8(i;*qlmRu{Qk*\fp獻n]Ļh,5(n*%k4ܭĊ /03z4=ZZ\B~eJD߇8^jsek--"o+fӇ-i3d"F܀=T5 SOl Rb1*G<捬} QLNw'?u@zxr- xJUṭD}Ozݯړܻ #"ANw.ƥadD'oFykMYUT6wOEx$W:ă\,u-*`8@]ޭ\-B눗r2W7vy;Ӛ{WiiI@n=5NNf2i c*ۛ,.N|-+CK9oe3?\T7SXãQS_[jW&ҳ;%:mM[FW!qZe^B6JJPqeRsww)0XU;ȧ K[DwZq$m^qLluH B|NO8i r׶Ɯut~$^\=pGCJsU=n>w7º:+]^k #‚FWiŴ,2N* )-|I"LagH>toޜǯZUw[:|G*%@$Zs\ qd $i 3"[O_ZƬézDw vq9tA8c:d|*ÇWGR{;#r]KTg<\؅ʕTd~Sӯ+iȑ'f{J]] ]@jv Sȣ-Mw!CXp}?ohW }7)t1`x93+MGfn.Z# P19 }¼GtۅD[{mE96 Es<{g|\):u=Un: zW][ĺUVf !A*#g'K̩Eӻf!> ?-#'?'?z&c%rz#>ƹSMERxp<=7y}^ o2)daT~y犾gϖ5vџMQ\?>#i*U}XQZ~Pw5 ((PEPEPJZ((J -LS)m JJB)MJCKJ`%bIN4INMPh4SCN4Ji4i(QE!1&m{ދ2 #UAaڦ n?I{԰v?*%dș>.$OsRWt$RUGjFˡѷu^ӽ)EU,ISउSOC:ӏjCi̷z[s֝KH:!hCüiJ?4J kC;xQFWe{]\%q,eblu ΰLޓCI.Yӣۡ!9Gܧ@چ5|K'_ҽskz#qs3ݐ }~xY񆕨3m)6_&C=Zn-G?<Њ;]cD22{ȭ߈:~Pgoǧ#xbl5%6>[@{x?siMNay[;NB jڐw$qTwi#"?'#iQ"]F)F>Wiwua)kydq5R}8piO>FYS`y}t椼u 輻xP~5Q gRWқgDFq\[ʲ/B+^$6R7#^?ڳ|K+4K1eTռ|U}v6b\I[=7?1TQ$gpzoW4{q5v%++uBb;^['Ey \8 V%GԺt.=+/|)$K%̓؆ێ=ס7t/iZ7qmHۙO1Nk $QEFQo+,揟kcr=;E޴`MB='O\뚯i+V{cm6 .`O~o5o \oURwэ;C׿=C|!vji4ei'7'{~閊6u{yR=oק?CԴi,ph-8\Tקh6(ּYD"Z5dGRm5muK# fg$dF.Hx# 1&އ vg;dp lsVU*qFт=|t N?yS{)c񢍷1AgUN~3ӐNN\Z#!{iRh$H2=jZÞ"׾F7kvlÎ}GO|3 7Ěj7X uc[&kPhQAE ( (QA JZ)PhR@ Sq1JE%%S))qE6E%0CN1 4JiSSI@)Si )4CHE8P #zj(ƿqk'ֆ*ћKF)iycoyHVqe&N¿:}hu+6y׈ݿ*LzcѿoAՓJ}}kv9VX<ksA ΖV&ֿ̞WҥKBJ^ʚqy7IVPji?μ[+-&b;Q8c|&/^Vy-h[lr zCmuyoop0za؏jj/,&&E˕,^b S~َrftm]Wu$t<iw+ӏuu_+ %lG([ ?T5uzo&2F~aT4 ^<W*J'SAeGgq< ,Q3"Y]Pp_KWR۬ggP%^R2j'F_Tr@pG뺥Askt=*} WɊTԓ̰OD\ȧ-.v>' >u{r{Um Ҭ!EtJ*[z7Yk6K&&<\[A>*iIf!',|0BFt}9oz\қ{X*_82zKiusz|48 uI|.(mxܿ5sVB]ۼڡ` V% [5><hXyq}?AU%u` \vuܝQ =sEfM8I8xšg-#\1e'7q\^G[.-A͹vʓAx'zUѢ]8 [Y0K?7^cNH&r F66+U?}º/ZC_]AMq$s#G"a*\3vɤx'l=+)l{ u0^4;G2i;sWQ-`Y>GoL~`?<#1ʤQNE܉קWNT_B6'hX$О>hnP=E7JgӮD̓єak5)C(R}= K蹩(<;Kmc*Bu(X@H8k&08<5jW+qS$dA(E&s`{J%Goq2dC('$ S[*ܼ$r8!reQ|<9χ<([h_?3B+Okxk]h,oZ̸7)quextgTFc;)MZa9'jt_H!ҪVGo pϴ~5t+{kD0,qsM<+> Tnp-,Wq\rsҽLe䴻KZ);,yT:`zm}'!A9^5[c0$Nw'S<Obcn}BG+(%c'|sy&"XVGsloE?^]O+ "y&jǀ̀8?׎ᵜ?ԅ̱KI2+Cm*y+Loÿ'Vg ՗ۨ_@Z\ykŤ4CPk|{?[ )-9@}Wg_'mZK]L$qa "EϦ(kXv5V` (Q@Q@ E-R@ !AmRi() )Ju4`!46Ӎ%0HiMiSH&!0ILӱIi9RP]21gYOOG^ tlag\kEpR5ʘd)kZCӣýe*XGPkc5xt )h Η{+S2iПZ aNw'zCKH ;m9&uiKkrK<O 2OQ5ƫXB ê~9SSOAJRb5dEt`*rO&-q5(W^1ziK\dZ=s`5t3RZ]o#6biG 獍)KWGβ͑OB#LJRM#H]IVR0AA\0?*WzE%pH`{^$o R8o*GD7uǬ8֬GԆ}7kԋ@CZ:^OFdpJ9U~k?!ivgv*qXIYMYfH/t1Ƴﯮ/< @J)AmQ sF)2U5"x5 kMF=:ԚZmy&TbTH\~d8$=_tB ^K$o G^}:{KḼd,=>7(T7 iNNEO"N 0a:v˹G~5k:дf Tlh&ե#ArRj;^y:5SM:ԝaC ~WM#1}yO R?ȎiWKH7Ez۩лIKA! b^iV[d! A>ȭ3TRҒLicmkX͔:T+FIGLn$)9x]KRk&"UV|`A8󑏺N9 +}BsAAGx#d6I0i-bW=vGsgܫ]XE:󊇒<Lw_olkA# e@ &Fr2d=Z%g؏>W\zv?^eDZZ 0ƳOΦ@2cn~q[t5I!jEZ槧FYX\sGp@OcWeH;c#5y%ySȯWtwЩ=Οz|/:@?D΃_',[`XDؖ0qFxeGO| CNML=q$ܸ=E{/Oq  ^S,SO##9+xLCQKS Iyk-Ԗ#8#*!XS)+AN (bTAh ThGMH[ܛY~R{7_)+6|c3޺}v+g#2rБVqgJ2[W0o ^?wlڲd@go8!HtDqp!?´Qu&iT(;n1,Ř䓒}Y ]1'3F=Z0%H##<׼qŸOՉ5|8U};k˵ח$ԈqGNARkDY#dSSGQR}*ɰƯ?P'UI!j ?FOƋ*+hn䷹eAF֝xzܴa =׌/MB9?. 8F`N?q!n~tKz7*G2B*KuA*xݭviF[Exÿ|d krsBza/oqb&$pYNCЃZ&0(JZ((4PvJ1KI@E6iSILbRbLbHiZC@CNi :C@)M%1 HiMi)i)X 9bE$86r真2E"Ɯ]JJIVW`tdt`pTƨ|oRhϥ! bzz`ӳpk|7^{X|NGuqXwuM反4O B/yDϸ㞹g'gJ)Yu0u+AP[>Ҿ첋caBnʭHҋވhuk8#L}c7'Ji>q'+%-@wRHxV=KYr//& r#-oJa]ycjs>\dʏTy3rY[>bnYy>aѽwȜ%,;FI8&׺a>73i?=-S3^T<;jZmo+>"^)d’H %̽xfI6muzހ.ٗ8exz &\/uEjl[|a >Q4/GEU:Rrf_W!vc*uUQJͽCk5%tp˴P(JA  +!pAN>O<oMu;0pa>9큜xuiƙ>&!h.8ӏ}@#}k|{tRtHpDcчxu}uѯdn R]mn' 4N| "d< }G]ϊ}QNL첕 1 )\gk߷z}H\Bș(%3TB=kMu3Elm!D%'pF9#8$Ӄ{OKҬu2iB2VA+=:MDQWf#ikP-@NCԣ)sO~FkʼA\^""]VX#}:^>` +ܑcw5ZX.88nAׅqЩkg+@. !L1^xoøYmC5ݼ6m"ɍHӡǨk  h5thK\"?^Sg##K_&؃N@TUe9kj?;\.kxgYb9%7 Cu^}M;SށfJϴr8#mRYӡgYVA5itz(@QEQIEJ(iJ S %-HibT%%-!4R`!h4&iC@ "HimRLӍ%! Wj>zW#͕&R7ּsI rr |y5$m.9:nZ:W8!:ҡHL\K,۔򧛄 r>'+lP&1jg O 9_ߎ+5;[ٵMS`ӟD^ZO$P{~-ªA.猟+~onW}`l 9B}.Omp=㚾b\O_EXƴS 0(6Ö_=GUJ5xP(χ5o@5T5ߡ+iG8j+r/599Vyq֯MxSy|/fjA++>֗1LzoQޱIT^fԪncLr:S֗c<"V#q\-4A4ot~6]b=CJk$IWGjԊ:JM OWlPX5`O~T]9$RX`_?iz֛yq%G)$mZO|T5 Q0*jr@{eѮG VmRVϲͦ{Rdŧ9f)OJ~Jٵ4(q}v>q?8Ӕݒ2PC3C~||%ZbeHmʵAiHR0:(*JS['̧v?Rk^1Z |59+]'zÞs7,Nʫlv_jVMJ$DS_={W-,@&7.tšᕒ?D: ĺn[Ks$*HNqIŊmIcF/?yv=rKyRG 霌 2hx"UiGգ-ւ0,~S fs>YjMXsCĚ" "=ؙ {b%<#4JQW8#v57l)u .ʤ;FHێ2:X30XHs[(2Gs7 g|#yo,і ^ Ƥzw}q]m3FK,m`7pHc29[%@\| yqdjXfR!.co*=JGqg!9+/Iݽm<ۓ(L@u‘Q&o4"lcs-8?jD63iڋyabn~8?̽})0#OYr4}+j笝6fd_u>I&> ^zq"'UMoYkjl,P*گ$⹛KfMQUŹxW;Fɦo+S ׃+69ޕĘ ~u?W[cc'Cv1Vr )$=Cehm9B}4/c?m?8qd:Jc/;ܧG'te@ ?j?sMQt0Ϟɟf~3ӉMK718xNU`N)8[gW e<:GZ$d,QMYŜHܣgj+cftخ#pfd?*3x^95֍P㢬D6XY[(ϕ JQֻc%%trJ..̡iZՋjP,з#<>{_=tBث^xJ?^)ELF{N|ȤK<$m+D٥Mɚ܄$yKhg|c[8^:d1[SFׯ b: n[_ 4w?-(ƌr$_Ǹ50yVaH(9c#u5UGpk;:^m!ǗgNVS-g^8-m'-qڽwRImaJ)O'XR9v7$)Fln0 [;-;K3 fñ$tq[%ƷOuŖIf@6xDF3vm^ker{N[I|c?ܗa"dU14rDnkXmgݥ7襎y_zwMJ{xX]]dd\+]EΰF`јe܍ s:X =98*2ˌ3㰪[-"gOOSЯbQ&B~_rN>V+mCQmr9hPNqt9ナ|~ڷe<[PR;~S;A oxF$h)cUqfqu,溂?ŚXc酸 {C_7U5=QgSdtagx瑓񍏋>EcDOchEQ]դ(((CJhB)M!JZCL4)ILBRZJbSө(RPCN4bR?3қُ{Nߧҟ,yڬP2vqn? {?qk=A/v<quަpyMq>2|7mJ#Lh->Iݓ>"ߏ,^>_-\ʘk~O֘9E2{lc/Qfe@ NErO.f-YSݓofL|cK+aR3Xu,$bIx:SȫzuМA:ǢGֲtW4RR } +>06~,n#AB(t# $)Q¾ip=rlz3KK~^psνAbD}<8k%ExL"*Imd#RM~9LMw>5+=R6&^Q~5mk7Vx.z o" B,Z{OD9/~TCcm״LJs+Нz-Kh/!>SV2kHŢ%i#!mSTuIH]C/( X-%S ֱ2?ҵO&*]H#zxޣ:W]E)ݨ*!IN=i)F>O_Mwk-I,G:ЏCQX^jCuoUΕ;LɨY$ybx}pjݽ>mEkqсc[dW}{k0."b=tas펴 mɶ4!Mא͐}D7-ޙp lw$r@1Qѝuq\՝;l{b]O*m{HZ)mkujN7vG$N# @#I>*%T$v[C^ɯh:?䐤\yn:=fJ~ >~D'm~] K⧇ZsE>W&Hg+ż nqvu} hwخ"yߊbZ3G>yⷾh'#zƿ=̚ kI[}H?7vǡ+Ch $ڡ Zzݼo<~ '5nh?¥l~.i>!KΟw!ڛcscohk ͓s,.d}W;ЌⴥY"*R[i*'tɿ'!Ǫ]hh1TN!.!dQjT?=R-O9_PSb% x@xQ8 '\Ͻ}8y)֝%;|}ק%j?j'UfE/NB=P~j9 B7~8ovGgHs2@D ~St& ^8?> aeppd鑓|Nۛ F۳vkfIϸ싖;Z( nmg%^@g Ğv_>x?F.~omuG"KC+Ԍ98cyK9&pG.ID _C׷9y56]7l7 )<$ nyq>\t]J?+$`+sf/n?o%#hq1tU?vN+N3jFѰL1F*vh*zv54|&T_>0՚[C2a.Jn#yHVf㙸*CL',>v#է#Ye Ő9*b8'-?QѴVQT)q$rcVdb <}R SWPrx$i24c9R3sNpA5+izzEy GʎIX I>SɞpGJ:[vPp*yW*66s6޵RI28F/euc+r 'ǜ~2Z~c_]QNU 2ݸw;[,,MfHᴷFcDF1C/awm[kls(vn?)p@uN<Z[3l|_ syُ{]=|wj^ՠ״h.6w<F0_O/Xb϶-zkX=*SZ*%-i) -HiݩRm1ES 4Ӎ!&%!i -!CKHiPQKHhi1vUgNN>c#bzc%XA)8`9^}1'F/V\q5M2<&~cOa)*mE*\o߀$3#ݓ4cU*3_TdZC|S>sP|[|S\$ԛL{>o>丏݇=@ a2϶&Ov^_z 3$T'7E9~Sg}η~(VF~kʞ~fش>,^>\N|?i+ϝoN HIOmL&4nj1VUWLQ[i?ҹ@<ΧɹdOӏϏ$hyENߧX(UgmovյpkX Hȼ>kMn$`OFX4͓RFjRpBa a]B%iId}H{T%\|Xȍ7ySHH|~WtZM!^0NSهL~u^mYA<CG>DL`~VcڑeE>~ĵJc%Y#ae9{yW{wzsyeܩ>zצh7v{;~F>j%-vȠLO,o$n0Fǥt|A4ҼJs#-lrJpïcj݌֧$nO^,Lg⩇5Zu<]'9JۍN}Dm?\5N.5Nz_𫔐0 Z2E X`85׎/]AIɽA++c wt?:rmͫ=ֹcM KskvG<wwg~.izGkc4yO ᾦ=#oٜ?3$ GЈ2q?[y?Щ,ZHuأJTv1ӯp^3u>}byYx=ޯ !h,q9jJXxCO\{uyvfqZs' 57W ndZcQ7،lh>0q_O0 0Hד|DZ84c"d-cbcϙ#|Ϯ~oaҵ]Z;>f$%taz]m2$UiAȓ 8I8?Ig4슿h d$'/z@Z(KFD܎IڥdS>&E7̾T̅H!w lo.cdc C 0C 8ֲPjZmy5nPXxa[>!iD-X-~7ӣEzLVrǐ:}TםD:C =*+mX~^?/ 8MZn2LҝNd%[F+ Ώ g18:U)iWFcgۀ?xԒ07 zsW-k02XgX.O Gc_y7'ʥ]Jqƌ\Mj+wwxىX*x"W]\]̴ܠV1޹ucܝ(*iza+>[]kZ"pTCn=HE5(sr+ut]-Ɍzko.<o ݼFC'ʮ~s'G S^xH[<*ᓺ{ְ9loQEF!EPPhRRL4 y)M!4S -!hLiM%0IN4hb>zgX%Sg4Dfv\OH&KrKbXz?sdF(aJT&\kJ([8a4yY:!~\T淓qi$׹k^2ҤfX?/C%i/-5$^sNGL+G ?||S:GWqp|ϝݗig $3Ĉ]O׿ϸwћr%sןZ7H@?ya~{y6?ke̋w)G}yPyS܏^w'S?yjewpŏ_za'΃丏ܯ=K?7~r=/)I (r$w1X(&>z3n~>?R&u87Ő+E]W,Pql2ӷ>jr[  2u?hi spzIR(x\!ޣWWsu?%C(~>}+MtYY` = EJJ~JEVNae#Koϐ~C<j?"Ҵ{$o%IP:^,։P{dVĈ ceb?k2(I6Z'a6e,JۯҽChU5G#|"k!^(n<%o^lpdC~zhͷNM^[<G]>7xōSHaW+紘};s^3UWwojK&kYGA1gs6]=؞mQǠ~{m?vkPb=uL^.&ocG5?ڍVfO޹``tbo$PX]i-neCsc'#>ƗZQKhgJUSި6XX9Q^6YXdz)&?tKG|O̍އI0rJPv>Qna !HR253su nY$cāY{8'Jڣ[̭K]wicd$.:vzKE̗ 'p NNsHہ'9߆vݷѺD"\Le;v;97:|[k %7RZy% ޛ=8ǠEYx@ymB{y\f!gG ~xu^.]Sv6aԙˬ 2b8 {Ηu>e+$B+.a8POp@99BWbE&ӑziorq뷠H XeuFx͘Y77+#ݶ##o5Ys#D75d֤qk' v#+c$sW-yohBӘ-7D|!휏vp01ېG7`8usֽ+Hi VT D9i̧'$zW7/ ŦDo,w-?Ѳy8o.8^9Õɣ֮%$!ч AiŅr\92PuI$]aE7q G( #!*AZRum9/$y>dbxA1f܉eFO JR 8ɒPE?ͺB-pj[Q32sPP9z^-4# Rc A1鎃Tmd clGXna)/;z>x9C|fzw:l~^~/#A#Y ut"J-u]> D.aGB+hMM\O袊 E)Rvi )5C6Hh(`4RSM4CINJCJi)Q@4!ևrV.,ϥJC( ak~v2Kr+=Mkn9ă +(N25YD 2,_'Un,jtS:GXqf9L_Rf헝r?T5zaso/=Bo߫AT}8>'>l?ܯ}i_;L9E<~ n:Z ]#~5/l6tm Lld+ɺdOӏϏg`t7V{I?f\z|IZKCTgm#S(+ x$tH t?ڥ;f O\8*ñ6 xnD36u#|nw{Fom\Ͻlh:Ŕm2`~xCϥQ.)x>DSܤˑ=_{8ݱ:aQ ^IQFg^i[~ kojwcIJ{]Ա}&rT_XǥRS&#kFx$ȼt5O»G/$;U iCZ>ARRo7JOaϞq᫟kDF-o.8eϨ׬H-f1#:IO}Myim}l^ATCJ{k[H"WAial𺜷~֡)Ldʻxzo r[He%eCf[cc9befuJJeg'}{c^$㑦^_>ןʥ\[ƾѼk 3J\$dE[,kf+ `W|?xN[\WĖ^?M?GeZEm$v򣷱4/4xr}sW2A ! L*φ}s:uA4:zatM$ AQ\R}>ˣ\k3%;"h֖VL38''S/֯uF;耂?TdW ?$7[QrW7`1_+|N·}JDL L]|ݕ}+7;WWm-/=G0$s ]bcH:-cWW%Ψ-Ҥej$>mwM)/W7}r2G#mZ+^^FF̑w=ᧉ9nQڰb8*B?x(o /W>o5 ܽL%E7s-?I)#18*9\(]~uwi].{X^ffMI\\uj#ZIܩQEsި 8o.|M#t#,= ֥ݻNbrYO(v.ZMI]8 $n`v˳+р2:`Vn6l wa{GNaھմ5K7UToQA k|Y-EV0w(d.sG=yGr;)Uc*l>-pïzKë>&B3` Ã8⼦'á@ NW%vz3uSc[BՑ'PJ1Gp0܎FI4ocӼ/cV:A} /u |uN9ëGo:^'RH+u U'y׵ x템py z/-u{DtHIfHY2HeG#$NRZ%gxtddnF77C9͏|g@JF\8 UċSUu \u!e~r9 SFco s h)7~~eceQ*i\elC2*TgNAYZ4Ci&FT*+s]~SYVei4K4#L'8t|9SUB?qt-]u$p^@A 1[JJMًIKEQMCIN4N=)h4SQE IJi)4%4ө(@4S)P(!?1kOx\u:(z!(3P?~PRܸԔv>~yZ+YnpRT?^Eg]pdC|_S}WeK~9> &(&A=iuB{_9O+@ho1K\sE/?Q[zrL"xU%ISP /"T.+ţI2"RfS[ R\^vk/tN8>|)kDW[_x*D{DAۢot~@l{I@cCbh |Uh6GHLwɷ` qYL [N݀T\*7T$9C\<-R+sY w0Y_B{ՔKWksf6 zLɜ} Lu"%R$IPF 7'5I d xu~=UU r6A?t}+>e'Π-2c^I޼?K iB'sp߇VIQgp~F'k|;㻋]ja&_ӹ=Id]ASȗIXe[bOb?+KOmS$z{EkNřNflV[G1x#ʩFH9;}kѥz3PjƓx݅-l߁& rzJRA'PnYksopSאj MM~cݑ.GJO_kM4*'MKrRPzqf#SXs\Vavg5^.klo㔩 ڤ`?7~>:Ɠq_ MLƳѣ1 g 5CTv!444('ERM}Wi0*T־%fOYl.lFѴ,r#_C;XV:7Ƭ[y1k-ɶ9<O?]o+iZKi1'W)+Ǧ;WԲO 0rZn|_WlFX58SdrѬПbΡbrx=E}4bmV׊Ѭ?`@R8o\ۓg} ppV O`M{?3bB/hIeJ6=6/o TRk`򯑭f;^f C&1OB=A>x={NtiLxj| ahbu.x>ڮ0zng)o[xVa#aR-pQZv?\<%jBG2{ RVqܨs299=|<^/~yһ)GjrU,.mo8Q ˓gj3Z43Mt|կi7:6( |:zOgeJ\;Ctv_xieRn'i=G|ǟP|3Xӧ/s`3 t=Jn Sy~Նrr4^s9cͻ'̤.C1;hؤ9 lCԵIm}j *z|{k\/ xnjG&ch c8)C0G$ ~%ϲ]t +s(Å9CkMnIm#g=ֽ'z-ǂEyrqan `֕*m[MNQ9*WBR^q8S|7]>YM:۱_=ԏjM|Q5ٞgIԳb1+u[]F@d[.*GWx^dtWRjˤk [s\GU{k] Eف4!IKI@i0SILcM`!Hii)!) )SM8`!JJu%1E?Y$?_֞rsY΅[YW9E>RZZ1@u 87Pǻ`8=GZu^Z]*_9d!dCѿWk>=ibn+C`!C`*Su{asWT\Ξwմ{^K~9 &]*CyrU:a]=A+3uj6ȟ>_ѝgVTuj>oc-/<OsndV}x#G;GJes\d̋2 ykjOu=ȩXC|o;}1gRtXVOK{Tt͔J418 ã^ A\Ue"Н 9)pt'OWtH^X̚ mYgVÏ_R=+ҁqw 2.X{>!*A@A%LExHSX;y/B8+wC`W>#h~̺hTu,:g:KcV\hGPj[wQHu2x +2hq5Վ\Ӧѥ[i6ج>3Q%4vME9c$Cz3y6i7B{ pv1rN/XLSНvgf/|q9/S%culIpGѾ_γhGD[E#:.g"99Ӟkm?Å{E2{EN{;Z2#Bwد~5k~(3ܪ~ S7QXͅw1DͭɡxE.`TyZP+`BjL~ |XTrst?}Wq! Y9ǯҮ%2S<_A^6]֡/{6cQ{}(kmN)Zޑ)T&%Eff+#9Oz㿻'lfqqǾ+ khQ̲m`8R~_ПҴgi.A#WGuEZz4đ%ɻE=;֮) #%-%?g]z|}d{dlE0zccJ|׏V)+1)8婡h&)W V Ǻpbr͞tÚo'm+Tr'r=}svm#G*-As C]|srw|taV'V'z@$]azA pk&qkj6S#LHD*G#$q+R}UB_)Yx !~lEgx6>X%߲ kNtRR)i-Tt5fҢ>z4iݧZXRJJSE2E ϥݩ֕fAL}&S!,T@RLF~kWe,t0W x&4s}y,?~0zQ()γ&6U@e@9C)VY 1~ Q+{WݑKL2trmͲiYy=ף~>*WOFqt=>ө !V]q[)HT_t>Gҵ4 w\xf>j[Y<<1,z~ ?:o3מ: p$n$xECXOsܺ{) ¾nWIb?ިFpeoCO8d@6\G?jc0:(?)L}~_4+2m&U@0VOҦ[kicʓTzCP"d9}[ǏQҚb668q?C֓W{mxȎAԁʭ i{09r,ŁGmQCSg*$8/ӷX*¥ -3/9E<꾵 fV/v5K\`E {b:t˯q5J L=6+%Yq!#qc %וs:2;ʒ'r<;ǦoDžv@.y]Es Ko"I5{N>k_+kÞ#[nBOrj.'߮lnGN?CLIam6BO0ںH|Үqw2MdRWG4)*AwbВRĩi-wbd[q^Xo̸z[G^s-r~( fE bb!K#8>j?^0^p'6LI AlТtmSO!-˵1G\SaQb ZAZk ܳi?Q Cڰl˭I{ieؤefw)+2'8AIs]W|Kĭ(@$zB:5ZŽ^y锎9hp8տxOfŶn@;Hn,oJ~-ѼA%@G#t>/5!&FCS߸e~yuěDߧ\'p(x+PA<+,,0Ov`tKwo%E)U{R:Vkd.-#Q+ۢ*x=U!%C=æH.ch捊8R;OFRA߅qldQ+\o&}}==t/b>56i1񾞼,3RѲz׈|swYҵ;&e >\p k)#?6S,92x?6l{$k/߃ڬ ^JeՑ{`[?QQNvw&p5$Imb'W䈫) -xA\(ϦOz×+ddkRJFsO_ϯ5?.R-'OX'$`LӸ9Z6m&w:/,uoJi.b̫By==+$xWѽՎJ';?gMj]WK*=i4@!3U[N:<rEBM2}>hh d u.ǝ~m_yz0B熆|^[ ?1O\=@f5EvWn1 _CsJ..錹41!v꧃گZbKv 1xHI+013;|/r*F98 >87ݾ⠣}KיZXLC; )nP"S#pAc9FÎ T1b30,?y{^[h,oeyJ{vP 0b%[.n捌?Fh2J$+ tqzw`ˆ1ɳ!t8 y:@IhW}̑};8 XٜO tNɷcVу+ AGt7Z=QQ:E㢧f7]CO_} )B惊JZc3[Y(Rw=i7Y#"1cǿ:PUve92a&u?؇XGwen?5PfWA x1?/=j6@ nD26bx߷2)8t]M0ʧkepT׊pÃ\eŜ Q̿תxoZfŵcdNZ܇VLIxəB؀I~&FH0kU9gITbOK(hG5J zNԵvN/^/Uף jR~5KFrPlK. uD1U2dU4;< *E 5Dyxx?xLʞW0%y 2N1략Pi<rd#"Es+35$g\ʥDv #l '=*"7=A Z.w̬xϯ'?Z|8Ѽ[rr*3<ǿcӚ_?Z~^ik#gSLV{?m .̖2XĜ\AO*bJ{om%! Cyɨx^oOZz-%ŮcR墻B8*A~''O׭H +65= Fv4:__DŽYr۰weǭhM wƫrketof}#3;M Ċ}(a p[&HdS%cS{K븵Ssuoqm)XŻNr/0y$0 rNkǾ*xMYd3.xFqӵC=+Wz_ͽ o#T*F19SKm,7 JJx8 A 7_(5684N m o ѻ&p[ I޳OjOdɀ3a8@"XJ6OR?ﯗBO?iW65²0$7gԎǃ A2c|Mqgc;K9쎄8qO:WwJxfE1Sf9#X7#9Wq qx3O8rXp9q׳=E-/|j%wXInS q2vHto"I펤t8׉_aO.A檑6ӱKqwǫzd-R2dr:ʷ<;.]NpQVᩬT ܭ6ݏTf^:@~&bB1Z~-% x10nw˞U`s\75&wpv^r#I.YYlz 5U1kqQ.b+-mukoEE*v: dيQʞêpkNxץ+iRi44M4CLS)CM4CINh4()9KIy'GSڟ{HZֳwgƧjZ?y ޴Ұ܂4MсV^JfGcFY: \2[}F!u?+RWZ5^2x`8*}z5Pp1ĒFiٯi t;RJ[GҼSL7OG&|G _W,vBͼ`n"vmIZ+,GFeX}Oqm%1ȑČHK[V]3ݣg+Zؑ?딝ǠZhͯr#(ɛ,!"\0>jc DX9޷4o d4Eʫ/~t7GpfwA/; ٗFïo{~@%Twf_*.%O=3ڧ1 o`?1L7GE [y<Bʈ2R']l <%lxĿֹC!FD~6k)TY<ץeR6Ɛ)r qm#`x_=+w(c# \w6MKc\57f9*jupE Դ7} n#Q}{cS27nUy9rݪӹ'k6m-V^X1ʞ==_. [ mxWqs ]['??Ҫ%i!ETu2Aӱ Xm?+_uIҴuभ#ԑ⻰YV[RVEtp_Ft U#wS+ 8VB!OGVbNr=Gr< md7V euw]ٞ?ҮRqRVc]ׄu[kqa4r;raI~fn|BW4y~Yc|#һ֕goiڱ$YTS\csc펭Tӎj<'0ƲB>I۷5Դ:'g Nv-6 _JٶM8R~i^Y!xE _Zg9aذ%8eviu1zc>X,CT?){:vtp犗S(ϖ\@wnݑ[8؜t=qք1l g˞[vnW 0!Qa[X ՙ ͍8pu㞵t+&أ˜mʞs?0ߵkۆY,JL\3zrӓqzt)f ᷙE#<8 :A32].V ,`Oݓ<}9"`ZKjwU(eyy;,GjjYnecH5^sd(.5(HPB:?xzyꌣQɭR.)-}dYCH"B7F$sؐz1%A` (zw*y>bh0q!(_`2O8-!5pA,vgla]}`;z$*2 \01kփnRrא;z[fg#!vRpxH8UCc8~]G,KmsOI㵆w;KH۞*c tK4q"[.\X̓{26 IwBX)fͿ kIc&E*B)zSx#k9ԇtҼ${+o_Úyjnݹtuֻ]ђ<򱦒 %)4m! S( EL})i(Iχu_@5~Ȼפ#ִf)qL@)i)å fw@o{GY" (ؒKJ(gH?CXԠĀG0߆ߡAKErkzY`pVDU{amz1t«yz%!%ٺ7֋n=m%МUoy_ɘ&|=Gi؝V5?:p)€(#?Z5/zpօ!hQb <I?jQK%>[`i n^@gۘ/>pO=Ar;*m>ObJ@=z0kՕPU i8#a=PʖAJ1/q"=DZȬgE3xWksi"J*qտGG*ӇO s p}U%Ռg%91)~+}+ qR8'0J}ToWp]٘,uFۘ:Ub@S!hHpfE2{: >!&@d.#ct|?Z&IEu s[J!4۳CƯ׉.tcܣ}GcֽKG-&'EQ2M?9{~=S+7pFV'vRĸ#KX|YIIn?[5^ݢ>싃I]N.:0)/|;:gf)$::q xQk0% ;?%?qBKu%k+j.'Iܮ+ =Vd8F[w8z@5fӵBc3 zqQx6]^UXL΀K+lT{ Z;nna\G+h)iH?֛Fj3iYR_) j|6Rh U⏈V,4 c~hF,d}B9+u WZغ*bql7fJWl']_n5fO RkDFE@&,Tpj d;POc5Ji{~c>$q^c6nͼ)%ihE۟N^|eac~JdG<1 H0# }wJSI@4ө AiHii)R~4<.j7kFE"^AZbR$ZZJ!^gx{@~сZ"= {m4u.)h0bC[KK@#bppyi1e/!hP7>Q\&+bnzVNt-4DP֣z̢ouȘmóu$Uuk>UI*u CU6S},.[SER%>{8ه*Fo ؟a8Ǣ Ь5k̋+B SIKLUw@ק3~C5z$z{IC[sE)I`%J@WMW ҒɷY۷ST7#QEzEZ[\mK[dr]|]us`yӱ.=_6ȡAVS':h.,f'B:2B;\,`?mN ֦ 斶u ,>d7Rұ*X^*Ѩ aKUOjzZ-n%U9G:cT6t6{};O|M`1ۥI u(X{`Ew>3֧Wcr1$gkzڹ9%n!p$Rם8FM#8Лjkе3T^B1gIYW>^0]kքRRBŰ$hOȦ>\QkݼֹoG$ YTuï{+O8FÝU~E>J{vu?߼$J_.!m. S 0;Ok|g>a>z,JUJUBX{ MdoHo8wJFm>w0ps퟼x\Fwn9:u\7Q]_Ë jSKq}b.t}t|A}X-؜K]R,qIv82G\03-q׌gypÐiY7*AR [*x46coߌzsu*J7tMi4.[$M!HKp+ r`]Mu fM *͖B}.CarAׂ9c`Ǯ0>ǡ܇+vKKFZyL8CH'![i&zYgТJᔝ`ilNH)|q߸.tCcme#p?U|= {9څ܈$n!szq uUX UuggBFNWWU56zw"(.@ef\GLP082y}|ݸ=7VKFA?qn}zY7n1:9<jK̉cƔu"!f rsIEt? uoɥ L2] #0 O "zG18G %(]?rHX30ԞkUS#si̺HzGb|yb>qV -b[v19+ C^ĒzaǬ*E8Ђ+6$G."aQ}o@?|'_A1Σ ƫDVH.Chf]ӱuܬ]n خbY#ia딇RQLx}j =;?**11@]--6i-~C5wKZF=~'h`ևc,Jȯ:-sS{q[a&*%"QHxf,BWT~ȷ);}=ҽ^u=ƚevܐ1H^~m;o}A'醮Zm Grd. $]X \E J0JqC7i[2+,*߾LqCϠjAV:?+N?knn_a,{{F5֚uzԯax_9#;>Wg̼;g a.(L7/WqZHZuWR8?R1®H|>5rLY,}:Ʃ13gC֧:téL;=qmY#% _TNZ9#O* 2? <+'Оڪs`5Z; 7י?Y٤d{{ש4w,:n2 jMtg('9 dYWˑAyS*Jnm㸏l9W;yjm= zTq z= u[@Q]G9bHj<7zGZO6bGn>9^b?pANJHdQ(s2.Gs-?MS,6 ʑ]pScR}k9aKV@ t1Q_1xM:{ |gh`x#؎Kc^vE{E:><d̪%﫰`=9ÑPFcLd͹\]u4?3Bz ljrcB$ :gMy+ emmyoͼPH8z/-|e߰jR `d&?|1"_CE"mzd#IsIYk%^Fa *s+oJn~kV'ou>'"{JUB_ٲp?zfֵuE8ҹ_ٞ_5(bO"Rݡt=4KBt#5Vu?z].N ԱC5gi+UP|8ǯj/dϘ.C6NNCM1՞FEmwio"y&r=F7g1u(̲gpqsu>"x)4d`T4d_m;=v0w(vЌsˆx<5C]J<;wvu#ÎAyϧ8~!Cnn ]A2O-HΖWwQm;ʰe^(OnM=`kJu\Ĉ,gоuRun{#^AWu΃I1D$wanp zz䦮y!+ IJi+B4!)(UPIKIBMG ZʹR{m*XJy 3~1گ)#QK@Qq)<x}wRۥ$^7WF cN$QKH)iY9w@t4\܏%FSE-:(ZZWCx}k'.GӥGRJ( MҿDzj#+K?&QWodVR NU2U#}U 6Gto֞)E^Q r%O'O#Ҧ]s0*mz·NRT%]>9Q,#a(:̠,= WӱmVҧ^m2HV$h` T^4qqWj zI"R0h U5uݤޯ?W*+m*y);7:i`UP_Y[=)4/dړ ?6Kk wHAuBG:u-K#h^;;[#u`zsҽcPo]gezlH 7`an#ᇱgIKch^0q<}Tߗ8Ǚ$~!G?OAz[0cՠW}kԴIb\[m8/Oqz,QFHz OU79sьwg*_tei6O>1cTrGOCZ̲`cqo฻#o "ub>taCNl2Bp_oEzFS PxO{m_D&>IᾇӭA&".WGGҲN1zu9W/ǿq/RTpq֍c3r?*xWEt0uQmڤ1;Õa;l 7*qEY1j,Rech>h܍'ˋv'ޣž+$PرE>{뗏+"T{bdhWEl{5:}ikr Y^s\-ޛ1G peZm5F" ! #rERfmwKYJ5BK 'c]q6fqա}bbYqIbOP&GuO; ^QEkZۻLwAc3+ܞ?1̬T%|-6o)57X=_>e6v"p \ JN,QM\mnI"d%2)ܪG@{Tk[{9^^U;HEz',T;ВKmJB|.N&$ă5#g=l tF.VJg޼Zh7F)VY!$6i|ٞCޥ<);]Ւ'b?q_>!2ie*v_O~vx< 77MZG26?ҭ|DtgКx@iYer?El>W>+_'ĺQ9l/'ΛlAү亷R3Ï5F=͚u+O/23gZ-&{Ϯ[xb q#19EcS\GG6hf559 gawY4 OX4H+| 9aÒUg2GT9<i򦝷vja)`le`@v:oWh8rNrrO2GUuSH0#>ne0r׷NY2svzG~9靭њZDybÂ1ЯpX֪00}>iJH#Cs9|wj-q\ xd^VY%US3m͞[6Na]2U$R#y;yW@@b8Ǿ9GT/ jg#6I H0k>h4]YwM4S"zc^m3Mpqq_szt{Su`qnϰ~AFʟj<4z'w/=pCJ:;RL@?=>toQl`|kѴY-be Szއ_(<}9A9(P}տ|3q_ ~V`UB+xmBm'UlkoT{{ϑ/uŸR6cX IMѼ7s$|רdz)^*{9ߣ8iuGmR5K]gI,_tU=rv=A!3IARRU JZJ-TĮMIc͕k3Suql-!Wϡ c[ $6i~ϽJ|c[O~- '*ʟB:j|V=Յ̂VRh9$ڝs;Fkl'}D-RO%\q('zFEGJ.  4S:Nuᡍ zGʵex{@pKH - Z( :~U Whޗ1֯7bKڀ8=Mt.}2o,>A{cV[QUTƉH#J62V[iRX!ȩk>MkWkKHߏ>SPb^bS[Tt2F 29U-#=$@PH QP"I4zh8*P8[?%:ІĢ(Ja?ҭZ>l)tXX9]aA⸭w=hH~_<}+qOr'մH渕 e'+_gS_\K̰~Q?cX zCOx>/c?SkWk!sQ;I{u%_WhyU Hf7[!9BOEE|֫=k@T6 pqcj>E=غ]8XU8_AZjM4dR:?5W0umpO?2>e5f3,2.+}֬xFv7?O)YwA㡨.G0*pASVɱ^knO'}:+He'{7 zi.Q-5E~nޕI!DZW6pV422?Q[][$8ʺ*9aI=+wMsUŪ_oWn`{vSѪKvU~_%%%tp2sQ%)3̑FI( ޙ=MKEQ'!J5\n]dZV9O}kixf37'8E|h[ bIJ={5_[I. QʅzsQphkHmJ#Ft``3'8U{ /֬-R@uX~^) h2մVX`qeΦO+[m\z^ih@qSn^*<8xݧC<ڷ,59a`\n:k 0s鷜ۦrO2Yz2ӣcSӑw? :N7uZqq# 9yz|k4;G)cKŎ^IʥGA vp=:^^O%fFuy GLjQIsҟ 29Q#fwZJF~*Wz7Lgtm:7RCr?)V{dTj,"[}A>)+' 8>YPTW` y+jiRHK4#]gcܕr=Yaux.ɂQǨ*+h )hG%PK'JYx?qZ!P"go֭̿U]G=xYU%zU-bF@uǰOGz\g?֐s\\hb~j^Yxh41kv?θWq{ЕhzJHDd8xk9R5Wϗt9d/u?ƾ˩yyW=G_]wj mCnw:JmkJӞBx?~`z h:NMH&c# ׭t8?kž67~j Z1+ciF$p}D%)-GEI# .\{ ϥ0yԫGfѢO6/Oω-5||#zza淥UΚ0n]2_`*uΛ+?A5/K|+<Uz3{+{rx1;qv1ꂄ>]ی~xSzr9緮I,)H;ݻ=I}}szn暤m9}1z)f+CyJokTyGNB+qVߎGר?ַ/K,`d˻>`N=8S+=b&Z˕B7ARآ[0VNN1r5}kK F drqeͯe2 [ xWe#30GkγRtunonu)B$@9CprGq[^$MCL@~$dxdu{Cw ylb8uZNWkoX:,.\&?01 jzya É~hafp=3{jfŜ 4{ɬ/ѤndkgQ)XH^6VSG4& Xu-%V=R-ZR"TQEckO7ZTԇ1HhIKE1 tWFGPEp:߄˖ѢFF{6<KzSN5IFje-ʌvWgqVy*Y ˅c h~}MsOsz{}'9;Yc'A4y#2zzXSJIe(0YY^=1  %G^}}EKT$ezWWIe"y|@B>{o?TYbo|7L7jCM a-u:TXڵ0u[=v&d*KGWP+ңYT^gR%'CG"e=Gڕ7C &(RCF@c+5jv-'RC/u;URYH*x.e96HA6l"FW=VjdÌ=6K(ǘYI~P~_VǪy,wwZ;A8d^G#%мccs,m]ۑqִ]mi:// 4n#;wB?xn,_loKKWW~`^H0G?\9lOq#z#1=;vUPx68vYIymPF-?3\nswHş nH{O??4ksj. +-QHQN!QԯB28U>S3WsѠK6֗#';{mS }-,;Olc.늞tOnsc 1XYhs8e038^[s'І9<#zPT'֭-rnv56yH܏pvfyFѷƪDX ׋BIR:H#ӠǦ՚ sNI01ѽ)ʖYtd77r8=x;;r6@>?ܔ*$G󟗨nNW$V6Ƅ O{\E9&)6r[Ri YZ pFrӝjThYZ)YJ+㻨ߔ#8;냏χy->Y|1BsvhJZCZ4ө!E%0 (#oi%?(Rih(vGeQGRƥ;9MZ=MS ($*z[! Q@˔QEQOqP]CynQ$#EXg-Y2i[z7޼W<2o`&G傞?x{+UκRmr!e}-{5 HP|pAEʎ7 OLٹ=~lgv ٖ)je=±D>[s!qG)*}63Xs (QoAe#b 78QV{ Ζ#lv> K%-@VvEkfZ%zH:5V2i5f`2i(x;6yrVmy묿1vPT<(v]{Z67crۧCXZ-E/g>Q\;ɴ"\ars_h0##(v=b?z^-GQrV_Ț(-><۴ǯmY?o/b/&d' !\b)Op uCd8z;+Rx:ePN@@ \g=T=筺7rWT01y< TsxݟbCvz((x}uק~g5\ӯicJl#<|Qk@uk5:IJm{2;-/lHyB6V;yO@ӏaTdcH-L[+V_[9=nz=H~MTB8 Warning: fopen(https://newsweekme.com/wp-content/uploads/2016/07/2016-07-27T072219Z_1408443447_LR1EC7R0KGXUD_RTRMADP_3_GSK-BRITAIN-780x439.jpg): failed to open stream: HTTP wrapper does not support writeable connections in /home/newsweekme/public_html/wp-includes/class-wp-image-editor.php on line 428

GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month's Brexit vote. REUTERS/Toby Melville/File Photo

By Ben Hirschler

LONDON, July 27 – GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signalling its confidence in the country despite last month’s vote to leave the European Union.

Britain’s biggest drugmaker, which had argued against Brexit before the referendum, believes the UK remains an attractive place for making medicines, thanks to a skilled workforce and relatively low tax rates.

The country’s so-called patent box boosts profits from patented innovations by halving the rate of corporation tax. This tax relief, which favours pharmaceutical companies, has come under fire in recent days from the opposition Labour Party.

GSK said on Wednesday it was investing in sites at Barnard Castle, in the north of England, Montrose, in Scotland, and Ware, north of London. It plans to increase production of next-generation respiratory drugs and biotech medicines.

The vast majority of these products will be exported.

“It is testament to our skilled UK workforce and the country’s leading position in life sciences that we are making these investments in advanced manufacturing here,” said Chief Executive Andrew Witty.

Business minister Greg Clark said GSK’s move was a clear vote of confidence in Britain and demonstrated that “there really is no place better in Europe to grow a business”.

The company, which will report quarterly results at 1100 GMT, has a large part of its global research and manufacturing cost base in Britain, even though nearly all its sales are generated overseas.

Witty, who is retiring next year, had said before the vote that Britain should remain in the EU, due to fears that Brexit could disrupt Europe’s unified system for drug regulation and hamper access to top scientific talent.

HELPED BY STERLING FALL

Despite this, the company, which will be helped by recent falls in sterling, has concluded that the country remains a good place to do business.

Britain accounts for nearly half of GSK’s worldwide research and development and around a third of its manufacturing. It has a total of nine UK manufacturing sites employing some 6,000 staff.

Uncertainty surrounding the vote to leave the EU in last month’s referendum has raised fears over corporate investment in Britain, which some economists fear could exacerbate difficult times ahead as the government negotiates future trade relations.

GSK’s substantial investment therefore gives some reassurance and follows signs that foreign buyers, lured by a plunge in the pound, are looking to snap up bargains in Britain, led by Japanese group SoftBank’s $32 billion swoop for chip designer ARM Holdings.

The board of French utility EDF, meanwhile, will meet on July 28 to consider a final investment decision on its $24 billion Hinkley Point C nuclear project in Britain.

The pharmaceuticals industry is a notable success story for Britain, directly employing more than 70,000 people and accounting for 25 percent of all business research and development spending.

Witty, together with AstraZeneca CEO Pascal Soriot, chairs an industry task force set up by the government to address regulatory and other issues facing the pharmaceutical sector following Britain’s decision to leave the EU.

GSK said the new investments would create some new jobs but it did not give a number.

At Barnard Castle, it will spend 92 million pounds on a sterile facility to make biotech drugs, while Montrose will get 110 million for a new unit making lung drug ingredients, and 74 million at Ware will expand production of its Ellipta inhaler.

Social Streams

Comments

comments

Facebook Comments

Post a comment